BTTC
Black Titan CorporationNASDAQFinancial Services$1.33-6.34%ClosedMarket Cap: $10.3M
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
24.44
PEG
0.43
P/B
0.00
P/S
3.83
EV/EBITDA
2658.68
DCF Value
$-3.70
FCF Yield
2.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
33.0%
Operating Margin
8.4%
Net Margin
7.8%
ROE
0.0%
ROA
0.0%
ROIC
0.0%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $0.00 | $-1.80B | $-0.47 |
| Q4 2025 | $2.7M | $1.80B | $0.80 |
| FY 2025 | $2.7M | $209.9K | $0.00 |
| Q2 2025 | $0.00 | $-689.0K | $-0.16 |
Trading Activity
Insider Trades
View AllFlores Garcia Francisco Osvaldodirector:
SellThu Mar 19
Mokhtar Firdauzdirector:
SellThu Mar 19
Chiam Brynner Zet Handirector, officer: Chief Financial Officer
SellThu Mar 19
Lin Shang Juofficer
SellThu Mar 19
Loh Jia Pei Gabrieldirector:
SellThu Mar 19
Company Info
Sector
Financial Services
Industry
—
Country
KY
Exchange
NASDAQ
Beta
1.41
Black Titan Corp. was formed for the purpose of effecting a merger between Titan Pharmaceuticals Inc. and TalenTec Sdn Bhd. It intends to explore and identify viable business opportunities. The company was founded on July 11, 2024 and is headquartered in Petaling Jaya, Malaysia.